Abstract

This study investigates the nonlinear optical (NLO) properties of a newly synthesized pyrimidine derivative, N-(4-(4-fluorophenyl)-6-isopropyl-5-(methoxymethyl)pyrimidin-2-yl)-N-methylmethanesulfonamide (PMMS), with potential applications in advanced optical devices. The structure of PMMS was confirmed by single-crystal X-ray diffraction (SCXRD), and its geometry was optimized using density functional theory (DFT) at the B3LYP/6-311++G(d,p) level. Key intermolecular interactions were analyzed using Hirshfeld surface analysis and 2D-fingerprint plots. Nonlinear optical properties, such as polarizability and hyperpolarizability, were investigated using an iterative electrostatic embedding method, showing significant enhancement in NLO behavior in the crystalline environment. PMMS exhibited a third-order nonlinear susceptibility (χ 3) superior to known chalcone derivatives, highlighting its potential for optical and photonic applications. Additionally, molecular docking studies revealed the potential of PMMS as a strong acetylcholinesterase (AChE) inhibitor, suggesting its possible therapeutic applications in treating neurodegenerative diseases, such as Alzheimer's. This study provides foundational insights into the NLO properties and bioactivity of PMMS, positioning it as a promising material for future optical technologies and pharmaceutical developments.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.